What is Genomics?
Genomics can be defined as a study of complete genetic material of an organism.
Human Genomics is focused on studying the Human Genome Sequence.
What is a Genetic Test?
A Genetic Test can diagnose a Genetic Condition.
Genetic testing is often done as a part of a genetic consultation. It is performed on a sample of blood and FFP (Formalin Fixed Paraffin)
Why Genetic Testing?
Genetic Testing is a type of medical test that indicates changes in chromosomes, genes or proteins. The results of a genetic test helps in ruling out a suspected genetic condition or helps in determining a person’s chance of developing or passing on a genetic disorder.
Oncology Genome Testing:
Locating & diagnosing genetic mutations or variations related to cancer, thereby designing a customized treatment plan. The molecular perceptions gained could make a momentous change in the way we look at individual cancers.
At Megavision Pathology Lab in Sangamwadi, Pune we provide all the Genomic & Molecular Testing. We provides all the major blood tests & diagnostic tests in pune.
No | Test | Cancer Type | Sample | TAT |
---|---|---|---|---|
1 | EGFR, ALK, ROS1 | Lung | FFPE | 12-14 days |
2 | EGFR, ALK, ROS1, RET, MET, HER2, PD-L1, KRAS, BRAF |
Lung | FFPE | 12-14 days |
3 | EGFR (858,790) | Lung | FFPE | 12-14 days |
4 | Comprehensive Lung – EGFR, ALK, ROS1, RET,MET,HER2,PD-L1, KRAS,BRAF,KDR,TP53 |
Lung | FFPE | 12-14 days |
5 | EGFR (8 Hotspots) | Lung | FFPE | 12-14 days |
6 | ER, PR, HER2 (IHC) | Breast | FFPE | 12-14 days |
7 | HER2 (Sequencing) | Breast | FFPE | 8-10 days |
8 | Treatment Type & Prognosis & Recurrence | Breast | FFPE | 5-6 weeks |
9 | ER, PR, HER2 ,BRCA1, BRCA2 |
Breast | FFPE | 3-4 weeks |
10 | ER, PR, HER2, BRCA1, BRCA2, PTEN, PIK3CA, TP53 |
Breast | FFPE | 3-4 weeks |
11 | BRCA1, BRCA2, PD-L1, TP53, MSI | Ovarian | FFPE | 3-4 weeks |
12 | Hereditary Breast and Ovarian Cancer (HBOC) | Breast and Ovarian | FFPE | 3-4 weeks |
13 | MSI | Colorectal, Ovarian, Gastric, Cervical, Hepatobiliary, Endometrial, Bone |
FFPE | 10 days |
14 | MGMT, IDH1, IDH2 | Glioma, Glioblastoma, Medulloblastoma, Astrocytoma, Chordoma, Ependymoma, Neurofibroma, Meningioma |
FFPE | 10-12 days |
15 | MGMT, IDH1, IDH2, 1p.19q | Glioma, Glioblastoma, Medulloblastoma, Astrocytoma, Chordoma, Ependymoma, Neurofibroma, Meningioma |
FFPE | 10-12 days |
16 | MGMT, 1p.19q, IDH1, IDH2, BRAF,BRAF-KIAA1549, TP53,CTNNB1, ATRX,TERT,H3F3A, RELA-C11orf95 |
Glioma, Glioblastoma, Medulloblastoma, Astrocytoma, Chordoma, Ependymoma, Neurofibroma, Meningioma |
FFPE | 3-4 weeks |
17 | KRAS, NRAS, BRAF, MSI | Colon & Rectum | FFPE | 10-12 days |
18 | KRAS, NRAS, BRAF, MSI, KIT, PIK3CA, TP53 |
Colon & Rectum | FFPE | 10-12 days |
19 | BRAF, KIT, PD-L1, TP53 | Melanoma | FFPE | 10-12 days |
20 | CDH1, HER2, PD-L1, MSI | Gastric | FFPE | 10-12 days |
21 | KIT, PDGFRA | GIST | FFPE | 10-12 days |
22 | KIT, PDGFRA, HER2, TP53, BRAF | GIST | FFPE | 10-12 days |
23 | HER2, PD-L1, CDH1 | Esophageal | FFPE | 10-12 days |
24 | BRCA1, BRCA2, ATM, TP53 | Prostate | FFPE | 3-4 weeks |
25 | ER, PR, MSI | Endometrial | FFPE | 10-12 days |
26 | AR, PD-L1, HER2, PIK3CA | Head and Neck | FFPE | 10-12 days |
27 | KIT, PDGFRA | Sarcoma | FFPE | 10-12 days |
28 | BRCA1, BRCA2 | Pancreatic | FFPE | 3-4 weeks |
29 | BRAF, RET | Thyroid | FFPE | 10-12 days |
30 | Multi Gene Panel-Solid Tumors | Solid Tumors | FFPE | 5-6 weeks |
31 | CYP2D6 Genotyping | Miscellaneous | FFPE | 2-3 weeks |
32 | PITX2 Methylation | Miscellaneous | FFPE | 2-3 weeks |
33 | Any Single Gene | Miscellaneous | FFPE | 10-12 days |
34 | Clinical Exome | Solid Tumors & Haem-Oncology | FFPE | 7-8 weeks |
35 | EGFR, ALK, ROS1, RET, MET, HER2, PD-L1, KRAS, BRAF, ER, PR, HER2, MSI |
Solid Tumors | FFPE | 12-14 days |
36 | MGMT, 1p.19q, IDH1, IDH2 | Glioma, Glioblastoma, Medulloblastoma, Astrocytoma, Chordoma, Ependymoma, Neurofibroma, Meningioma |
FFPE | 10 days |